Last Updated on January 17, 2023
Gjensidige, for non-native speakers an unpronounceable name, is a quality Norwegian insurer. I’ve been long since the IPO in 2010, and in this analysis of Gjensidige I briefly bring forward some arguments why I still own the stock (and why intend keeping it).
Historical performance – boring is good:
Gjensidige has delivered significant alpha since the IPO in late 2010: CAGR of 18%.
What are the reasons for Gjensidige’s outperformance?
- Gjensidige is headquartered in Oslo, Norway, and is the biggest Norwegian insurance company. The market share is 25%. (If has 25%, Tryg 19% and Fremtind 13%). In Sweden, Denmark and the Baltics Gjensidige has a smaller market share: 2, 7 and 8%.
- A long history of successful underwriting: roots can be traced back to 1816.
- The Nordic insurance market is dominated by just a few players, making the market close to an “oligopoly”.
- Perhaps unknown to many investors, the Nordic region has better or at least the same return as US markets over the last 50 years. It’s a good place to invest your money.
- The customers are the biggest owners. The customer-governed Gjensidige Foundation owns about 62% and passes dividends further as a customer dividend to the insurance customers in Norway. On average this has resulted in a 10-15% discount for the customers.
- The market has natural entry barriers from insurers outside the region due to the very low operating costs. Gjensidige has a cost/expense ratio of 15%, much lower than any insurer outside the Nordics (except Admiral plc).
- The brand is very important in the Nordics. Customers are loyal, unlike the outside markets. Their logo (the watchman) is iconic. The retention rate is 88% for private customers and 92% for business as of 1H2020. Scores for both customers and employees are high.
- Recession-proof: Gjensidige was not listed during the GFC in 2008/09 but the operational performance was little affected. The same goes for 1H 2020 during Covid-19. Insurance is one of the last things people stop paying.
- It’s a dividend stock, there is not much growth. 80% of the earnings are expected to be paid out. No buybacks.
- Solvency margin estimated at 283% if no dividend is paid for 2019, while estimated at 221% if the dividend is paid as planned. Thus a solid balance sheet.
- 1h 2020 showed record underwriting profits and an 11.1% return on equity.
An important part of the insurance operations is the “float”, ie how they manage the return on future liabilities. Gjensidige is not aiming for spectacular investment returns and has thus little in equities and real estate (mostly located in Oslo and the surrounding area).
As of 30th of June 2020, the composition of the portfolio looked like this:
- Money markets: 8%
- Bonds: 64%
- Convertible bonds: 2%
- Other bonds: 10%
- High yield bonds: 2%
- PE funds: 2%
- Property: 8%
- Equities: 3%
- Other: 2%
The investment portfolio has returned these numbers in percent:
Investment return in 1H 2020 was 1.9%.
Return on equity (ROE):
Insurers are mostly valued on earnings and return on equity. Gjensidige has a pretty impressive average return on equity:
The return for 1H 2020 was 11.1%, on par with above 20% for the second year in a row.
Gjensidige is not a growth stock. However, the earnings have gradually climbed since the IPO, but in the long-term, I believe the growth will be like inflation and perhaps a tad more. The market is mature, and expansion is mainly in the Baltics.
Gjensidige aims to pay out 80% of the earnings as dividends. The dividend for 2019 (7.25 NOK) is currently put on hold and planned paid later. The historical payments look like this:
The main reason for operational excellence is of course due to low costs and low loss ratios. All the big insurance underwriters in the Nordics have very low combined ratios, thus operating very profitably:
The combined ratios between Gjensidige’s segments look like this:
The Baltic region has a high cost ratio but offers huge potential if costs continue falling.
Since the IPO much of the gains have come from a steady increase in P/B ratio:
Insurance companies are often valued at P/B. The better ROE, the higher the premium to book. The P/B ratio has increased from 1.5 at the IPO to 3.5 today. Assuming a future ROE of 20%, you are investing at 5.71% ROE (20 divided by 3.5). This is why it’s always preferable to invest in companies that can redeploy earnings. Unfortunately, Gjensidige has no way of redeploying all of its profits.
The P/E ratio looks like this:
By investing in Gjensidige you can’t expect much growth as this is a very mature and competitive market. Another potential negative factor could be a sudden rise in inflation. Price growth has been benign for 40 years, but central bankers might start a “race to the bottom” with competing easing and money printing. Inflation means assets need to be replaced at higher prices than the premiums received. Because insurance usually involves paying out claims many years after writing the insurance, inflation needs to be addressed. Any sudden increase could be detrimental. However, I consider this scenario as rather slim.
Perhaps needless to say, the opposite, very low interest rates, means lower profits from the investment portfolio.
The historical performance of 18% annually is unlikely to continue unless the multiple expansion continues (if P/B was still at 1.5 the CAGR would be just 9%).
Gjensidige is an “income” stock as growth is slow. That does not mean it’s a bad investment. Considering the “oligopoly” market and operational excellence I believe the stock is priced fairly at today’s prices.
What kind of returns can we expect? By using the late John Bogle’s very simple formula of calculating future returns, we can play with some numbers:
3.8% (current ordinary dividend yield) + 1% (annual bonus dividend yield) + 4% (earnings growth) – 0% (multiple expansion) = 8.8%.
Obviously, this will not set the world on fire, but in today’s zero-interest environment this looks pretty good to me considering the “safe” business model.
Disclosure: I am long Gjensidige. I am not a financial advisor. Please do your own due diligence and investment research or consult a financial professional. All articles are my opinion – they are not suggestions to buy or sell any securities.
(This article was published on the 4h of August 2020.)